Literature DB >> 7694240

Aminophylline induced atrial fibrillation.

P Varriale1, S Ramaprasad.   

Abstract

Atrial fibrillation (AF) with a rapid ventricular response was induced by intravenous (i.v.) aminophylline during treatment for symptomatic pulmonary disease in three patients who had no evidence of underlying heart disease or previous cardiac arrhythmia. Serum theophylline concentration was therapeutic in two patients and toxic in the third. Previous reports of AF related to aminophylline have underscored its association with toxic serum theophylline concentration. Conversion to sinus rhythm occurred at a time interval (9-14 hours) appropriate to the serum decay of aminophylline, after its cessation. A shortened atrial refractory period and dispersed recovery of excitability consequent to aminophylline may engender multiple reentrant circuits and lead to AF. i.v. diltiazem was more effective than digoxin in the ventricular rate control of AF prior to conversion to sinus rhythm.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7694240     DOI: 10.1111/j.1540-8159.1993.tb00987.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

1.  Attenuation of the side effect profile of regadenoson: a randomized double-blinded placebo-controlled study with aminophylline in patients undergoing myocardial perfusion imaging. "The ASSUAGE trial".

Authors:  Rami Doukky; Raysa Morales Demori; Sidharth Jain; Roy Kiriakos; Victor Mwansa; James E Calvin
Journal:  J Nucl Cardiol       Date:  2012-03-07       Impact factor: 5.952

2.  Aminophylline at clinically relevant concentrations affects inward rectifier potassium current in a dual way.

Authors:  Nuno Jorge Dourado Ramalho; Olga Švecová; Roman Kula; Milena Šimurdová; Jiří Šimurda; Markéta Bébarová
Journal:  Pflugers Arch       Date:  2022-01-26       Impact factor: 3.657

3.  Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Authors:  Ravi K Mareedu; Ihab B Abdalrahman; Kodlipet C Dharmashankar; Juan F Granada; Po-Huang Chyou; Param P Sharma; Peter N Smith; John J Hayes; Robert T Greenlee; Humberto Vidaillet
Journal:  Clin Med Res       Date:  2009-11-17

Review 4.  Oral theophylline for chronic obstructive pulmonary disease.

Authors:  F S Ram; P W Jones; A A Castro; J A De Brito; A N Atallah; Y Lacasse; R Mazzini; R Goldstein; S Cendon
Journal:  Cochrane Database Syst Rev       Date:  2002

5.  Caffeine induces Ca2+ release by reducing the threshold for luminal Ca2+ activation of the ryanodine receptor.

Authors:  Huihui Kong; Peter P Jones; Andrea Koop; Lin Zhang; Henry J Duff; S R Wayne Chen
Journal:  Biochem J       Date:  2008-09-15       Impact factor: 3.857

Review 6.  Atrial Fibrillation: The Science behind Its Defiance.

Authors:  Maureen E Czick; Christine L Shapter; David I Silverman
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

7.  Aminophylline Induces Two Types of Arrhythmic Events in Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Simon Klimovic; Martin Scurek; Martin Pesl; Deborah Beckerova; Sarka Jelinkova; Tomas Urban; Daniil Kabanov; Zdenek Starek; Marketa Bebarova; Jan Pribyl; Vladimir Rotrekl; Kristian Brat
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.